The invention relates to a method for providing control data for an eye surgical laser (12) of a treatment apparatus (10) for removing tissue (14). A control device (18) ascertains (S10) a corneal geometry of a cornea (22) and an ocular wavefront (32) of a human or animal eye (16) from predetermined examination data. Further, a corneal wavefront (28) is ascertained (S12) from the corneal geometry by means of a physical model, an internal wavefront (34) is calculated (S16) from a difference of the ocular wavefront (32) and the corneal wavefront (28), a wavefront (36) to be achieved is calculated (S18) from a difference of a preset target wavefront (38) and the calculated internal wavefront (34), a target corneal geometry (40) is ascertained (S20) from the wavefront (36) to be achieved by means of the physical model, wherein the target corneal geometry (40), which results in the wavefront (36) to be achieved upon a passage of the input wavefront (30) through a target cornea with the target corneal geometry (40), is determined by means of the physical model, a tissue geometry to be removed is calculated (S22) from a difference of the corneal geometry and the target corneal geometry (40), and control data for controlling the eye surgical laser (12), which includes the tissue geometry to be removed for removing the tissue, is provided (S24).

A method for altering an eye color of a patient with a color alteration procedure is disclosed that may include imaging the iris with an image sensor prior to the color alteration procedure to generate an image of the iris. A mapping of the iris may be generated from the image. The mapping may include a number of regions corresponding to varying absorption coefficients of a treatment wavelength in the stromal pigment of the iris. A laser system may be set, based on the mapping, to deliver laser light at a laser power sufficient to cause elimination of at least a portion of stromal pigment in the iris. The laser light may then be delivered with the laser system.

Certain embodiments provide a vacuum generation system with an override PID controller, a proportional valve, and a vacuum generator. The override PID controller allows the vacuum generation system to control the operating range of supply air pressure that is provided to the vacuum generator. By controlling the operating range of the supply air pressure, the vacuum generation system is able to avoid entering the decreasing or non-monotonic region of the vacuum generator.

The invention concerns a method for determining a minimum value of L.A.S.E.R. energy necessary to form, by using a LASER source, a gas bubble in an ocular tissue, the method comprising: acquisition (200) of a reference image, emission (210) at a sampling point, of a L.A.S.E.R. beam, acquisition (220) of one (or more) current image(s) of the ocular tissue, detection (230) of one (or more) gas bubble(s) by comparing the current image(s) and the reference image, determination (240, 250) of the minimum value based on the detected gas bubble(s).

Systems, methods, and computer-readable media for integrating and optimizing a surgical suite. An ophthalmic suite can include a surgical console, a heads-up display communicatively coupled with a surgical camera for capturing a three-dimensional image of an eye, and a surgical suite optimization engine. The surgical suite optimization engine can performs a wide variety of actions in response to action codes received from the other components in the surgical suite. The surgical suite optimization engine can be integrated within another component of the surgical suite, can be a stand-alone module, and can be a cloud-based tool.

An apparatus for disruption of tissue. The apparatus includes a housing; a source of pulsed laser radiation; and an optical waveguide. The optical waveguide is configured to transmit the pulsed laser radiation from the source of pulsed laser radiation, and is coupleable to the source of pulsed laser radiation at a proximal end of the optical waveguide to receive the pulsed laser radiation from the source of pulsed laser radiation. The apparatus also includes a driving mechanism coupled to the optical waveguide for controllably changing the position of the optical waveguide relative to a distal end of the housing.

An ophthalmic laser system for generating a first beam at a first wavelength on a first beam path and a second beam at a second wavelength on a second beam path, and directing optics to selectively direct the first wavelength or the second wavelength to a treatment beam path. The ophthalmic laser system a reflex coaxial illuminator comprising a reflex mirror movable on an from a axis a position out of the treatment beam path to a position in the treatment beam path to direct illumination into an illumination path coaxial with the treatment beam path and a safety interlock only allowing operation of the ophthalmic laser system on the first beam path if the reflex coaxial illuminator is in a first position and allowing operation of the ophthalmic laser system on either the first beam path or the second beam path if the reflex coaxial illuminator is not in the first position.

An imaging probe comprises a camera or endoscope with an external detector array, in which the probe is sized and shaped for surgical placement in an eye to image the eye from an interior of the eye during treatment. The imaging probe and a treatment probe can be coupled together with a fastener or contained within a housing. The imaging probe and the treatment probe can be sized and shaped to enter the eye through an incision in the cornea and image one or more of the ciliary body band or the scleral spur. The treatment probe may comprise a treatment optical fiber or a surgical placement device to deliver an implant. A processor coupled to the detector can be configured with instructions to identify a location of one or more of the ciliary body band, the scleral spur, Schwalbe's line, or Schlemm's canal from the image.

An imaging probe comprises a camera or endoscope with an external detector array, in which the probe is sized and shaped for surgical placement in an eye to image the eye from an interior of the eye during treatment. The imaging probe and a treatment probe can be coupled together with a fastener or contained within a housing. The imaging probe and the treatment probe can be sized and shaped to enter the eye through an incision in the cornea and image one or more of the ciliary body band or the scleral spur. The treatment probe may comprise a treatment optical fiber or a surgical placement device to deliver an implant. A processor coupled to the detector can be configured with instructions to identify a location of one or more of the ciliary body band, the scleral spur, Schwalbe's line, or Schlemm's canal from the image.

An imaging probe comprises a camera or endoscope with an external detector array, in which the probe is sized and shaped for surgical placement in an eye to image the eye from an interior of the eye during treatment. The imaging probe and a treatment probe can be coupled together with a fastener or contained within a housing. The imaging probe and the treatment probe can be sized and shaped to enter the eye through an incision in the cornea and image one or more of the ciliary body band or the scleral spur. The treatment probe may comprise a treatment optical fiber or a surgical placement device to deliver an implant. A processor coupled to the detector can be configured with instructions to identify a location of one or more of the ciliary body band, the scleral spur, Schwalbe's line, or Schlemm's canal from the image.